<DOC>
	<DOCNO>NCT01647529</DOCNO>
	<brief_summary>Objective study investigate intracameral level ganciclovir follow topical application 0.15 % ganciclovir gel ( VIRGANÂ© ) Cytomegalovirus ( CMV ) anterior uveitis endothelitis . Thirty patient diagnose CMV anterior segment infection , either uveitis endothelitis , positive aqueous real time PCR ( RT-PCR ) and/or positive tetraplex PCR CMV form ganciclovir treatment past 1 month , recruit study take informed consent . active CMV anterior segment infection confirm positive aqueous real time PCR ( RT-PCR ) form ganciclovir treatment past 1 month recruit study . Patients give 0.15 % ganciclovir gel 1cc 5 time day 6 week . Following 6 week treatment , tear aqueous sample collect . Aqueous send RT-PCR CMV status . Ganciclovir drug level tear aqueous measure HPLC method . Clinically , degree intraocular inflammation , Intraocular pressure ( IOP ) central corneal thickness ( CCT ) record baseline post-treatment .</brief_summary>
	<brief_title>Topical Administration 0.15 % Ganciclovir Gel CMV Anterior Uveitis / Endotheliitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Age 21 Patients diagnosed anterior uveitis endotheliitis positive aqueous real time PCR ( RTPCR ) and/or positive tetraplex PCR Cytomegalovirus ( CMV ) Patients relapse recurrent anterior segment disease PCR positive CMV aqueous Have VIRGAN form ganciclovir therapy past 1 month Consent undergo anterior chamber tap give aqueous tear sample study Able undergo relevant test ( corneal pachymetry laser flare cell photometry ) Able come subsequent followup visit CMV anterior uveitis associate retinitis Other cause hypertensive anterior uveitis / endotheliitis HSV , VZV infection Patients form ( topical , local systemic ) ganciclovir therapy past1 month . Patients allergic ganciclovir Patients require systemic intravitreal ganciclovir therapy Immunocompromised patient Positive HIV , Hep B Hep C Not keen participate study Patients incapable , either law mental state , give consent right . Patients either unable unwilling keep scheduled appointment adhere aspect protocol Patients pregnant breastfeed Any specify reason determine clinical investigator .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cytomegalovirus</keyword>
	<keyword>uveitis</keyword>
	<keyword>endotheliitis</keyword>
	<keyword>ganciclovir</keyword>
</DOC>